Proliferative Diabetic Retinopathy
📧 Sign up to get email alerts when something new happens for Proliferative Diabetic Retinopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. [Phase 2]
Phase II randomized, open-label study evaluating pegaptanib (Macugen) intravitreal injections plus panretinal photocoagulation for high-risk…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Morphological and Functional Retinal Changes Following Retinal Photocoagulation [Phase 4]
Phase 4 trial updates retinal morphology and function after retinal photocoagulation in patients with proliferative diabetic retinopathy and…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Squalamine for the Treatment in Proliferative Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial of Squalamine for proliferative diabetic retinopathy has completed; no trial results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging [Phase 1, Phase 2]
Phase 1/2 trial evaluating ranibizumab for persistent diabetic neovascularization assessed by wide-field imaging in proliferative diabetic r…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Vitrous Analysis in Proliferative Diabetic Retinopathy
This entry reports the completion of a clinical trial evaluating vitreous analysis in proliferative diabetic retinopathy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy [Phase 4]
A Phase 4 randomized trial evaluated intravitreal bevacizumab for proliferative diabetic retinopathy and related retinal complications. The …
-
CLINICAL_TRIALS withdrawal · 2014-03-05Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy [Phase 3]
Phase 3 trial of intravitreal pegaptanib sodium (Macugen) versus sham for tractional retinal detachment and vitreous hemorrhage in prolifera…
-
CLINICAL_TRIALS research · 2013-12-09Clinical Trial Update: PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy [Phase 4]
This is a Phase 4 clinical trial update comparing PASCAL laser versus ETDRS laser in combination with intravitreal ranibizumab, versus ranib…
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone [Phase 2]
A Phase 2 clinical trial update evaluating intravitreal ranibizumab as a preoperative adjunct before vitrectomy for proliferative diabetic r…
-
CLINICAL_TRIALS research · 2013-09-19Clinical Trial Update: Gene Expression in Patients With Epiretinal Membranes
A ClinicalTrials.gov update describes a gene-expression study in patients with epiretinal membranes related to Proliferative Diabetic Retino…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy [NA]
This is a completed clinical trial evaluating vitreous levels of Cysteine-rich 61 in patients with proliferative diabetic retinopathy.
-
CLINICAL_TRIALS research · 2013-08-13Clinical Trial Update: Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy [Phase 4]
Phase 4 clinical trial evaluating folic acid, vitamin B6, and vitamin B12 in diabetic retinopathy; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy
This completed clinical trial studied serum and intraocular levels of erythropoietin and vascular endothelial growth factor (VEGF) in adults…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) [Phase 2, Phase 3]
A Phase 2/3 clinical trial of intravitreal ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy has completed and p…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy [Phase 4]
Phase 4 clinical trial update reporting completion of intravitreal bevacizumab for proliferative diabetic retinopathy.
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy [NA]
A completed clinical trial comparing small-gauge vitrectomy to conventional vitrectomy for proliferative diabetic retinopathy, sponsored by …
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy [Phase 1, Phase 2]
Completion of a Phase 1/2 trial evaluating intravitreal ranibizumab in combination with panretinal photocoagulation for proliferative diabet…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery [Phase 1]
Phase 1 trial evaluating ranibizumab to treat rubeosis iridis in diabetics before cataract surgery, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy
The study assessed compliance with ophthalmic follow-up examinations and reported surgical outcomes in proliferative diabetic retinopathy. I…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) [NA]
A completed clinical trial evaluating Macugen (pegaptanib) for its effects on surgical outcomes and VEGF levels in diabetic patients with pr…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy [Phase 1]
Phase 1 clinical trial evaluating intravitreal injections of Macugen (pegaptanib sodium) given at least 7 days before vitrectomy for tractio…
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED) [Phase 4]
A Phase 4 clinical trial update evaluating extended dosing of Macugen (pegaptanib sodium) for proliferative diabetic retinopathy.
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy [Phase 2]
This Phase 2 trial evaluated combining panretinal photocoagulation with ranibizumab for proliferative diabetic retinopathy and has completed…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab [Phase 2]
Phase 2 clinical trial evaluating ocular growth factors in proliferative retinopathies before and after intravitreal bevacizumab has complet…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy [Phase 3]
A Phase 3 trial evaluating the combination of laser treatment, ranibizumab, and triamcinolone for proliferative diabetic retinopathy has com…